TB Online is no longer maintained. This is an archive of the site. For news on TB please go to:
https://globaltbcab.org/
Universal treatment of multidrug-resistant TB is possible within current budgets with generic production
Polly Clayden
Aug. 3, 2016, 1:03 p.m.
Generic production could make novel multidrug-resistant tuberculosis (MDR-TB) regimens available for US $53–507 per treatment course according to data presented at TB2016.
To read the full article, click here.
Source: HIV i-Base